Amaryl

AssetAlso called HOE 490, NSC-759809, Glimepiride, Niddaryl

Stage
Approved, not sold in the US
Modality
Small molecule
Target
ABCC8
3
Indications
69
Trials
1
Developer

Approved by the FDA on Nov 30, 1995 (NDA020496). Not sold in the US: Drugs@FDA marks every US product that holds it discontinued. FDA

Indications

3

In the full profile

  • Target and mechanism3
  • Owner and partners1
  • Trials69
  • Evidence for its targets3
  • Competitors12
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets